To determine whether the effectors of the COL11A1 signaling, Src, Akt, and AMPK, also play a role in upregulating FASN in ovarian cancer cells, we blocked these signaling molecules using pharmacological inhibitors and measured the expression of FASN. This evidence concerns the gene AKT1 and ovarian carcinoma.